CR9563A - Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micromizado, y sus sales - Google Patents

Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micromizado, y sus sales

Info

Publication number
CR9563A
CR9563A CR9563A CR9563A CR9563A CR 9563 A CR9563 A CR 9563A CR 9563 A CR9563 A CR 9563A CR 9563 A CR9563 A CR 9563A CR 9563 A CR9563 A CR 9563A
Authority
CR
Costa Rica
Prior art keywords
chlorophenyl
salts
immediate release
pharmaceutical formulations
piridilmetil
Prior art date
Application number
CR9563A
Other languages
English (en)
Inventor
Juergens Kai
Backensfeld Thomas
Funke Adrian
Thode Kai
Wagner Torsten
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR9563A publication Critical patent/CR9563A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Formulaciones farmaceuticas solidas de liberacion inmediata y con una carga elevada de droga que comprenden (4- clorofenil)(4-(4-piridilmetil)- ftalazin-1-ilo) no micronizado, y sales del mismo aceptables para uso farmaceutico.
CR9563A 2005-06-07 2007-12-06 Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micromizado, y sus sales CR9563A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05090166A EP1731153A1 (en) 2005-06-07 2005-06-07 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)¬4-(4-pyridylmethyl)phthalazin-1-yl| and salts thereof

Publications (1)

Publication Number Publication Date
CR9563A true CR9563A (es) 2008-02-20

Family

ID=34938467

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9563A CR9563A (es) 2005-06-07 2007-12-06 Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micromizado, y sus sales

Country Status (21)

Country Link
EP (2) EP1731153A1 (es)
JP (1) JP2008542420A (es)
KR (1) KR20080031005A (es)
CN (1) CN101242840A (es)
AR (1) AR053889A1 (es)
AU (1) AU2006256852A1 (es)
BR (1) BRPI0613393A2 (es)
CA (1) CA2610975A1 (es)
CR (1) CR9563A (es)
DO (1) DOP2006000127A (es)
EC (1) ECSP078038A (es)
GT (1) GT200600242A (es)
IL (1) IL187905A0 (es)
MX (1) MX2007015494A (es)
NO (1) NO20080065L (es)
PE (1) PE20070319A1 (es)
RU (1) RU2007147951A (es)
TW (1) TW200716115A (es)
UY (1) UY29582A1 (es)
WO (1) WO2006131393A1 (es)
ZA (1) ZA200800112B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958616A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion

Also Published As

Publication number Publication date
DOP2006000127A (es) 2006-12-15
RU2007147951A (ru) 2009-07-20
PE20070319A1 (es) 2007-04-12
KR20080031005A (ko) 2008-04-07
JP2008542420A (ja) 2008-11-27
EP1731153A1 (en) 2006-12-13
WO2006131393A1 (en) 2006-12-14
ECSP078038A (es) 2008-01-23
BRPI0613393A2 (pt) 2011-01-11
ZA200800112B (en) 2010-06-30
NO20080065L (no) 2008-03-06
EP1888072A1 (en) 2008-02-20
AR053889A1 (es) 2007-05-23
CN101242840A (zh) 2008-08-13
CA2610975A1 (en) 2006-12-14
GT200600242A (es) 2007-02-09
AU2006256852A8 (en) 2006-12-14
UY29582A1 (es) 2007-01-31
IL187905A0 (en) 2008-03-20
MX2007015494A (es) 2008-02-22
TW200716115A (en) 2007-05-01
AU2006256852A1 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
UY31647A1 (es) Forma de dosificación farmacéutica para la administración oral de inhibidor de tirosina quinasa
CL2017001847A1 (es) Una formulación sólida de dosificación farmacéutica
MX2009010289A (es) Composiciones para administracion nasal.
ECSP077243A (es) Formulación de pelet de liberación extendida que contiene pramipexol o una de sus sales farmacéuticamente aceptable, un método para su fabricación y su uso
CL2011002781A1 (es) Compuestos (e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol y (r)-(e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol; composicion farmaceutica que los comprende; y uso en el tratamiento del cancer.
CR20110110A (es) Composicion farmaceutica
CR10573A (es) Derivados del pirazol como inhibidores del citocromo p450
SV2009002857A (es) Formas de presentacion farmaceutica solidas de administracion oral con liberacion rapida de principio activo
ECSP088296A (es) Compuestos terapéuticos
ECSP10010224A (es) Formulaciones líquidas de hormona luteinizante (lh).
EA201001857A1 (ru) Фармацевтическая лекарственная форма для немедленного высвобождения производного индолинона
UY33201A (es) Compuestos de pirazol como antagonistas de crth2.
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
ES2555778T3 (es) Mejora de la biodisponibilidad de principios activos con función amidina en medicamentos
MX2020004107A (es) Tabletas de deferiprona de liberacion retrasada y metodos de uso de las mismas.
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
MX2022004523A (es) Formulaciones de liberacion controlada para sustancias fisiologicamente activas altamente lipofilicas.
ECSP13012832A (es) Compuestos de pirazol como antagonistas de crth2
CR9577A (es) Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)
UY29952A1 (es) Composiciones faramacéuticas que comprenden 4-(4-fluoro-2-metil-1h-indol-5-iloxi)-6-metoxi-7-(3-(pirrolidin-1-il)propoxi)quinazolina o una sal farmacéuticamente aceptable del mismo, procesos de preparación y uso
ECSP078038A (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales
AR058047A1 (es) Administracion de inhibidores de dipeptidil peptidasa
ES2561813T3 (es) Aplicación tópica de nimesulida y tiocolchicósido
CU20070271A7 (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-4-piridilmetil) ftalazin-1-ilo] no micronizado y sus sales

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)